Mitra Capital LLC purchased a new position in Luminex Corporation (NASDAQ:LMNX) during the 2nd quarter, according to its most recent disclosure with the SEC. The fund purchased 96,700 shares of the medical instruments supplier’s stock, valued at approximately $2,042,000. Luminex Corporation accounts for 7.6% of Mitra Capital LLC’s holdings, making the stock its 8th largest position. Mitra Capital LLC owned approximately 0.22% of Luminex Corporation as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the business. State Street Corp grew its holdings in shares of Luminex Corporation by 6.1% during the 2nd quarter. State Street Corp now owns 1,071,007 shares of the medical instruments supplier’s stock worth $22,620,000 after purchasing an additional 61,218 shares in the last quarter. Voya Investment Management LLC grew its holdings in shares of Luminex Corporation by 1.9% during the 2nd quarter. Voya Investment Management LLC now owns 92,553 shares of the medical instruments supplier’s stock worth $1,955,000 after purchasing an additional 1,737 shares in the last quarter. OxFORD Asset Management LLP grew its holdings in shares of Luminex Corporation by 48.6% during the 2nd quarter. OxFORD Asset Management LLP now owns 186,562 shares of the medical instruments supplier’s stock worth $3,940,000 after purchasing an additional 61,047 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of Luminex Corporation by 2.3% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,757,980 shares of the medical instruments supplier’s stock worth $37,129,000 after purchasing an additional 39,094 shares in the last quarter. Finally, Citadel Advisors LLC grew its holdings in shares of Luminex Corporation by 92.6% during the 2nd quarter. Citadel Advisors LLC now owns 235,260 shares of the medical instruments supplier’s stock worth $4,969,000 after purchasing an additional 113,139 shares in the last quarter. 77.95% of the stock is currently owned by institutional investors.

In related news, Director Robert J. Cresci sold 19,631 shares of the firm’s stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $18.98, for a total transaction of $372,596.38. Following the sale, the director now owns 260,358 shares of the company’s stock, valued at approximately $4,941,594.84. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 6.90% of the company’s stock.

LMNX has been the topic of several recent research reports. Jefferies Group LLC reissued a “hold” rating and set a $21.00 price objective on shares of Luminex Corporation in a report on Friday, June 9th. Zacks Investment Research lowered Luminex Corporation from a “strong-buy” rating to a “hold” rating in a report on Tuesday, July 4th. ValuEngine lowered Luminex Corporation from a “hold” rating to a “sell” rating in a report on Saturday, July 8th. BidaskClub lowered Luminex Corporation from a “hold” rating to a “sell” rating in a report on Friday, July 28th. Finally, TheStreet lowered Luminex Corporation from a “b” rating to a “c+” rating in a report on Monday, August 7th. Two analysts have rated the stock with a sell rating, four have assigned a hold rating, one has issued a buy rating and one has assigned a strong buy rating to the company’s stock. Luminex Corporation has a consensus rating of “Hold” and an average target price of $21.40.

COPYRIGHT VIOLATION NOTICE: “Mitra Capital LLC Invests $2.04 Million in Luminex Corporation (LMNX) Stock” was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this story on another publication, it was stolen and reposted in violation of United States and international copyright legislation. The correct version of this story can be accessed at https://www.thecerbatgem.com/2017/10/06/mitra-capital-llc-invests-2-04-million-in-luminex-corporation-lmnx-stock.html.

Luminex Corporation (NASDAQ:LMNX) traded down 1.02% during trading on Friday, reaching $20.45. The company’s stock had a trading volume of 35,529 shares. Luminex Corporation has a 1-year low of $17.64 and a 1-year high of $23.62. The company’s 50 day moving average price is $19.60 and its 200-day moving average price is $19.86. The stock has a market cap of $901.25 million, a P/E ratio of 63.31 and a beta of 0.29.

Luminex Corporation (NASDAQ:LMNX) last released its quarterly earnings data on Monday, August 7th. The medical instruments supplier reported $0.20 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.09 by $0.11. Luminex Corporation had a return on equity of 4.81% and a net margin of 4.72%. The company had revenue of $76.50 million for the quarter, compared to the consensus estimate of $75.45 million. During the same quarter last year, the business posted $0.33 EPS. Luminex Corporation’s revenue for the quarter was up 19.2% on a year-over-year basis. Equities analysts forecast that Luminex Corporation will post $0.53 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 13th. Investors of record on Friday, September 22nd will be issued a dividend of $0.06 per share. This represents a $0.24 annualized dividend and a dividend yield of 1.16%. The ex-dividend date of this dividend is Thursday, September 21st. Luminex Corporation’s dividend payout ratio (DPR) is 75.00%.

About Luminex Corporation

Luminex Corporation develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries. The Company’s products are focused on the molecular diagnostic testing market, which includes human genetics, personalized medicine and infectious disease segments.

Want to see what other hedge funds are holding LMNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Luminex Corporation (NASDAQ:LMNX).

Institutional Ownership by Quarter for Luminex Corporation (NASDAQ:LMNX)

Receive News & Stock Ratings for Luminex Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Luminex Corporation and related stocks with our FREE daily email newsletter.